Anna Farago
Hematology & Oncology · Boston, MANPI 1114185527
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $77,496 of the $101,968 with a category attached, or 76.0%. 11 manufacturers reported payments, led by Bayer at 30.1% of the total.
Across 86 payments — averaging $1185.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$31K
- AstraZeneca$30K
- Boehringer Ingelheim International GmbH$14K
- F. Hoffmann-la Roche AG$7K
- Merck$5K
- E.r. Squibb & Sons, L.L.C.$5K
- plus $11K from 5 others
Across 103 payments — averaging $7331.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$385K
- Genentech, Inc.$138K
- Bayer$122K
- AbbVie$72K
- Amgen$33K
- F. Hoffmann-la Roche AG$5K
- plus $1K from 1 others
What the payments were for
- Consulting fees$77,49676%
- Speaking & faculty fees$4,6045%
- Travel & lodging$18,38918%
- Food & beverage$1,4791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 16 | $30,736 |
| AstraZeneca | 21 | $29,616 |
| Boehringer Ingelheim International GmbH | 3 | $14,188 |
| F. Hoffmann-la Roche AG | 14 | $6,584 |
| Merck | 7 | $5,077 |
| E.r. Squibb & Sons, L.L.C. | 9 | $4,924 |
| Astrazeneca UK Limited | 9 | $3,478 |
| AbbVie | 1 | $2,500 |
| Genentech, Inc. | 3 | $2,447 |
| Pfizer | 1 | $1,250 |
| Genentech USA, Inc. | 2 | $1,168 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$101,968 in reported general payments places this provider in the 85th percentile of 374 hematology & oncology providers in Massachusetts.
Other hematology & oncology in Boston
- David ScaddenBoston$2.6M
- Sara TolaneyBoston$799K
- Matthew DavidsBoston$693K
- Julio HajdenbergBoston$583K
- Paul RichardsonBoston$523K
- Seth WanderBoston$464K
- Corey CutlerBoston$454K
- Hanny Al-SamkariBoston$412K
- Rupal BhattBoston$380K
- Matthew Vander HeidenBoston$355K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.